newsfilter
← Latest News
ACCESS Newswire·

Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results

Revenues increased 14% for the quarter compared to prior year and 13% year-to-datePositive cash flow from operations for the quarter with $5.2 million of cash at December 31, 2024Year-to-date net loss decline of $1.1